BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32998931)

  • 1. Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial.
    Hüttner FJ; Rooman I; Bouche G; Knebel P; Hüsing J; Mihaljevic AL; Hackert T; Strobel O; Büchler MW; Diener MK
    BMJ Open; 2020 Sep; 10(9):e040406. PubMed ID: 32998931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study.
    Roth S; Springfeld C; Diener MK; Tjaden C; Knebel P; Klaiber U; Michalski CW; Mieth M; Jäger D; Büchler MW; Hackert T
    BMJ Open; 2019 Aug; 9(8):e028696. PubMed ID: 31434770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce postoperative pancreatic fistula after distal pancreatectomy: the PREBOT
    Klaiber U; Sauer P; Martin E; Bruckner T; Luntz S; Tjaden C; Probst P; Knebel P; Diener MK; Buchler MW; Hackert T
    BMJ Open; 2020 Sep; 10(9):e036815. PubMed ID: 32878758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial.
    Mack CE; Klaiber U; Sauer P; Kohlhas L; Baumann L; Martin E; Mehrabi A; Buchler MW; Hackert T
    BMJ Open; 2023 Sep; 13(9):e065727. PubMed ID: 37730416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pylorus resection versus pylorus preservation in pancreatoduodenectomy (PyloResPres): study protocol and statistical analysis plan for a German multicentre, single-blind, surgical, registry-based randomised controlled trial.
    Renz BW; Adrion C; Klinger C; Ilmer M; D'Haese JG; Buhr HJ; Mansmann U; Werner J;
    BMJ Open; 2021 Nov; 11(11):e056191. PubMed ID: 34845079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
    Wei M; Shi S; Hua J; Xu J; Yu X;
    BMJ Open; 2019 Dec; 9(12):e033452. PubMed ID: 31818843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a randomised controlled trial to compare postoperative complications between minimally invasive and open DIStal PAnCreaTectomy (DISPACT-2 trial).
    Probst P; Schuh F; Dörr-Harim C; Sander A; Bruckner T; Klose C; Rossion I; Nickel F; Müller-Stich BP; Mehrabi A; Hackert T; Büchler MW; Diener MK
    BMJ Open; 2021 Feb; 11(2):e047867. PubMed ID: 33619204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.
    Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC
    BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.
    Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
    Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
    [No Abstract]   [Full Text] [Related]  

  • 10. Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen-plasmin pathway.
    Kristjansen KA; Engel Krag A; Schmidt H; Hölmich LR; Bønnelykke-Behrndtz ML
    BMJ Open; 2024 Feb; 14(2):e077012. PubMed ID: 38309757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
    Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
    BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
    Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
    Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial.
    Luo H; Galvão DA; Newton RU; Tang C; Dean A; Jasas K; Johansson M; Yusoff I; Spry N; Taaffe DR
    BMJ Open Gastroenterol; 2021 Jun; 8(1):. PubMed ID: 34099463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ward-based Goal-Directed Fluid Therapy (GDFT) in Acute Pancreatitis (GAP) trial: study protocol for a feasibility randomised controlled trial.
    Froghi F; Soggiu F; Ricciardi F; Gurusamy K; Martin DS; Singh J; Siddique S; Eastgate C; Ciaponi M; McNeil M; Filipe H; Schwalowsky-Monks O; Asis G; Varcada M; Davidson BR
    BMJ Open; 2019 Oct; 9(10):e028783. PubMed ID: 31601585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
    Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
    BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol for PREPARE: a phase II feasibility/safety randomised controlled trial on PeRiopErative Penicillin AlleRgy TEsting.
    De Luca JF; James F; Vogrin S; Chua K; Fletcher L; Nazareth J; Guha R; Hardidge A; Douglas N; Carruthers J; Stewardson A; Cheng AC; Johnson D; Douglass J; Peel T; Trubiano J
    BMJ Open; 2023 Feb; 13(2):e067653. PubMed ID: 36828661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
    Haldar R; Ricon-Becker I; Radin A; Gutman M; Cole SW; Zmora O; Ben-Eliyahu S
    Cancer; 2020 Sep; 126(17):3991-4001. PubMed ID: 32533792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
    Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
    Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).
    Ridolfi L; de Rosa F; Fiammenghi L; Petrini M; Granato AM; Ancarani V; Pancisi E; Soldati V; Cassan S; Bulgarelli J; Riccobon A; Gentili G; Nanni O; Framarini M; Tauceri F; Guidoboni M
    BMJ Open; 2018 Aug; 8(8):e021701. PubMed ID: 30082356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer.
    Tibdewal A; Agarwal J; Mummudi N; Noronha V; Prabhash K; Patil V; Purandare N; Janu A; Kaushal R; Kannan S
    BMJ Open; 2021 Feb; 11(2):e041345. PubMed ID: 33589450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.